New drug might be an advance against eczema. Rocatinlimab is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment was stopped. Read more
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — An experimental drug may one day be a cure for eczema, a new trial suggests.
Move to electric cars will save lives and billions in health care costs. Replacing vehicles powered by gas and diesel with electric ones will pay big dividends for Americans’ health, a new study finds. Read more
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — As the United States moves towards a world in which electric vehicles (EVs) have fully replaced fossil fuel-driven engines, can Americans look forward to reliably cleaner air and better health?
Big U.S. genetics study is already helping participants. Called “All of Us,” the study aims to eventually include at least 1 million people, in an effort to accelerate medical breakthroughs. Read more
People are also reading…
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — More than 155,000 people who have taken part in a massive genetic study orchestrated by the U.S. National Institutes of Health (NIH) have already gotten something in return — personalized DNA results that tell them whether they have an increased risk for certain health conditions.
Long COVID has taken the lives of more than 3,500 Americans. Research is revealing that the damage caused by a COVID infection poses a long-term risk to some who survive their bout with the coronavirus. Read more
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Long COVID is a collection of symptoms — brain fog, chronic fatigue, shortness of breath, stomach pain — that can torment people for months and even years on end.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Health News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
